Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2
Atterling Brolin, K.; Lange, L. M.; Navarro-Jones, E.; Jasaityte, S.; Ye Beh, Y.; Fang, Z.-H.; Iwaki, H.; Jones, L.; Klein, C.; Kleinz, T.; Leonard, H. L.; Mata, I.; Noyce, A.; Okubadejo, N. U.; Saffie Awad, P.; Screven, L.; Tan, A. H.; Toffoli, M.; Vitale, D.; Singleton, A.; Blauwendraat, C.; Nalls, M. A.; Morris, H.; the Global Parkinson's Genetics Program (GP2),
Show abstract
In the Global Parkinson's Genetics Program (GP2) we aim to advance precision medicine by integrating large-scale clinico-genetic data from diverse populations worldwide. We investigated potentially trial-eligible carriers of pathogenic and high-risk GBA1 and LRRK2 variants and conducted a global precision-medicine survey across GP2 sites. Among 65,509 individuals with Parkinson's disease, we identified 9,019 (13.8%) potentially trial-eligible genetic variant carriers, including 6,789 GBA1, 2,084 LRRK2, and 146 dual GBA1-LRRK2 carriers. Individuals were distributed across multiple global regions, many of which currently lack active gene-targeted trials, highlighting a global disparity between relevant variant carriers and the availability of disease modifying treatment trials. GP2's unified framework supports equitable recruitment for gene-targeted therapeutic studies and helps address critical gaps in Parkinson's disease genetics and future therapeutic development.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease 97%
- Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease 96%
- Genome-Wide Association and Population-Tailored Polygenic Risk for Parkinson's Disease in Taiwan 95%
Similar papers in this journal
- Insights on Genetic and Environmental Factors in Parkinson’s Disease from a regional Swedish Case-Control Cohort 93%
- Voice of the patient: Emergence of new motor and non-motor symptoms in early Parkinsons Disease? 92%
- Quantitative Digitography Solves the Remote Measurement Problem in Parkinson’s disease 92%
Similar papers in this journal
- Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations 96%
- Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S Variant 96%
- Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.